Brokerages Set Bath & Body Works, Inc. (NYSE:BBWI) Target Price at $45.06

Shares of Bath & Body Works, Inc. (NYSE:BBWIGet Free Report) have been assigned an average rating of “Moderate Buy” from the eighteen research firms that are covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $45.06.

BBWI has been the subject of several research reports. JPMorgan Chase & Co. set a $47.00 target price on Bath & Body Works in a report on Thursday, February 27th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. TD Cowen increased their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $40.00 to $48.00 in a research report on Friday, February 28th. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th.

Get Our Latest Stock Report on BBWI

Institutional Trading of Bath & Body Works

Several large investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of Bath & Body Works by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company’s stock worth $1,093,306,000 after buying an additional 208,036 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its position in Bath & Body Works by 4.3% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 10,235,086 shares of the company’s stock worth $396,815,000 after purchasing an additional 422,973 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Bath & Body Works by 5.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company’s stock worth $329,317,000 after purchasing an additional 445,887 shares during the period. Alliancebernstein L.P. increased its holdings in shares of Bath & Body Works by 35.6% during the 4th quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company’s stock valued at $200,768,000 after purchasing an additional 1,360,264 shares in the last quarter. Finally, Anomaly Capital Management LP lifted its stake in shares of Bath & Body Works by 38.3% in the 4th quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company’s stock valued at $188,456,000 after purchasing an additional 1,346,752 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Up 4.0 %

NYSE:BBWI opened at $31.85 on Friday. The stock has a fifty day simple moving average of $34.84 and a 200-day simple moving average of $34.16. The company has a market cap of $6.82 billion, a price-to-earnings ratio of 7.77, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works has a twelve month low of $26.21 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWIGet Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, equities research analysts predict that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works declared that its board has initiated a share repurchase program on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 6.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a yield of 2.51%. Bath & Body Works’s dividend payout ratio is currently 21.98%.

About Bath & Body Works

(Get Free Report

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Featured Stories

Analyst Recommendations for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.